Global New Chemical Entities (NCE) CDMO Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global New Chemical Entities (NCE) CDMO market size was valued at US$ 2689 million in 2024 and is forecast to a readjusted size of USD 5687 million by 2031 with a CAGR of 11.1% during review period.

New Chemical Entities (NCE) refer to new compounds that have not yet been approved for any therapeutic use during the drug development process. These compounds are usually obtained through the synthesis or discovery of new molecules and have new activities or therapeutic potential. NCE is usually the first step in drug development, and after evaluating its safety and effectiveness in clinical trials, it may be applied for marketing. CDMO (Contract Development and Manufacturing Organization) refers to a company that provides drug development and production services, usually working with pharmaceutical companies to help them develop and manufacture NCE. CDMO can provide a range of services from preliminary compound synthesis, process development, to the production of drugs for clinical trials and commercial production. In short, NCE is a newly developed drug ingredient, and CDMO is a service provider that specializes in helping pharmaceutical companies develop and produce NCE.



This report is a detailed and comprehensive analysis for global New Chemical Entities (NCE) CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global New Chemical Entities (NCE) CDMO market size and forecasts, in consumption value ($ Million), 2020-2031

Global New Chemical Entities (NCE) CDMO market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global New Chemical Entities (NCE) CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global New Chemical Entities (NCE) CDMO market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for New Chemical Entities (NCE) CDMO

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global New Chemical Entities (NCE) CDMO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

New Chemical Entities (NCE) CDMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Peptide NCE

Oligonucleotide NCE

Other

Market segment by Application

Tumors

Cardiovascular Diseases

Other

Market segment by players, this report covers

KATSURA CHEMICAL CO., LTD

Regis Custom API

Neuland Laboratories Ltd.

Aspen API

Sai Life Sciences

Fermion

Dipharma Francis Srl (Dipharma)

Cohance

Suven Pharma

Syngene

Aarti Pharmalabs Limited (APL)

Cerbios-Pharma SA

PharmaBlock Sciences Nanjing Inc

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe New Chemical Entities (NCE) CDMO product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of New Chemical Entities (NCE) CDMO, with revenue, gross margin, and global market share of New Chemical Entities (NCE) CDMO from 2020 to 2025.

Chapter 3, the New Chemical Entities (NCE) CDMO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and New Chemical Entities (NCE) CDMO market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of New Chemical Entities (NCE) CDMO.

Chapter 13, to describe New Chemical Entities (NCE) CDMO research findings and conclusion.